Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
GSHD
|
Robyn Mary Elizabeth Jones
Director |
SELL
Open market or private sale
|
Indirect | 18,101 Reduced 61.52% |
$2,052,653
$113.4 p/Share
|
Nov 10
2020 |
GSHD
|
Mark Evan Jones
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 18,101 Reduced 61.52% |
$2,052,653
$113.4 p/Share
|
Nov 10
2020 |
DEA
|
Darrell W Crate
CEO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 31.19% |
$107,250
$21.45 p/Share
|
Nov 10
2020 |
USPH
|
Graham D. Reeve
COO |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 14.01% |
$104,230
$104.23 p/Share
|
Nov 10
2020 |
USPH
|
Glenn Mc Dowell
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 11,507 Reduced 44.3% |
$1,221,123
$106.12 p/Share
|
Nov 10
2020 |
AGYS
|
Robert L. Jacks Jr.
CIO |
SELL
Open market or private sale
|
Direct | 1,400 Reduced 11.3% |
$44,254
$31.61 p/Share
|
Nov 10
2020 |
PACB
|
Michael Hunkapiller
Director |
SELL
Open market or private sale
|
Direct | 1,304,348 Reduced 54.39% |
$18,586,959
$14.25 p/Share
|
Nov 10
2020 |
CARA
|
Joana Goncalves
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 5.99% |
$30,000
$15.0 p/Share
|
Nov 10
2020 |
TPIC
|
Thomas J Castle |
SELL
Open market or private sale
|
Direct | 1,300 Reduced 100.0% |
$51,350
$39.5 p/Share
|
Nov 10
2020 |
TFFP
|
Stephen Rocamboli
Director |
SELL
Open market or private sale
|
Direct | 21,278 Reduced 100.0% |
$322,149
$15.14 p/Share
|
Nov 10
2020 |
TFFP
|
Kirk Allen Coleman
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 93.75% |
$226,800
$15.12 p/Share
|
Nov 10
2020 |
TFFP
|
Glenn R. Mattes
President and CEO |
SELL
Open market or private sale
|
Direct | 108,830 Reduced 91.58% |
$1,631,362
$14.99 p/Share
|
Nov 10
2020 |
TUSK
|
Arty Straehla
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.34% |
$8,900
$1.78 p/Share
|
Nov 10
2020 |
ROLL
|
Steven H. Kaplan |
SELL
Open market or private sale
|
Direct | 60 Reduced 1.03% |
$9,262
$154.36 p/Share
|
Nov 10
2020 |
LEGH
|
Curtis Drew Hodgson
Director |
SELL
Open market or private sale
|
Indirect | 4,109 Reduced 0.13% |
$61,306
$14.92 p/Share
|
Nov 10
2020 |
AX
|
Thomas M Constantine |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 30.65% |
$148,185
$32.93 p/Share
|
Nov 10
2020 |
JSDA
|
Heavenly Rx Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,000,000 Reduced 13.33% |
$40,000
$0.02 p/Share
|
Nov 10
2020 |
IR
|
Viseras Enrique Minarro |
SELL
Open market or private sale
|
Direct | 54,429 Reduced 77.22% |
$2,311,600
$42.47 p/Share
|
Nov 10
2020 |
VPLM
|
Dennis Chang
SECRETARY |
SELL
Open market or private sale
|
Direct | 144,500 Reduced 0.44% |
$2,890
$0.02 p/Share
|
Nov 10
2020 |
VPLM
|
Barbara Baggio |
SELL
Open market or private sale
|
Direct | 766,100 Reduced 1.26% |
$15,322
$0.02 p/Share
|
Nov 10
2020 |
CBDS
|
David Tobias
CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.59% |
$12,000
$0.6 p/Share
|
Nov 09
2020 |
TTD
|
Susan Vobejda
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 3,274 Reduced 9.4% |
$2,619,200
$800.0 p/Share
|
Nov 09
2020 |
ARES
|
David B Kaplan
Co-Founder |
SELL
Open market or private sale
|
Indirect | 24,471 Reduced 2.55% |
$1,118,569
$45.71 p/Share
|
Nov 09
2020 |
PEN
|
Arani Bose
Director |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.02% |
$25,599
$255.99 p/Share
|
Nov 09
2020 |
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 30,100 Reduced 0.03% |
$10,438,078
$346.78 p/Share
|
Nov 09
2020 |
TXN
|
Kyle M Flessner
Sr. Vice President |
SELL
Open market or private sale
|
Direct | 24,955 Reduced 31.96% |
$4,033,477
$161.63 p/Share
|
Nov 09
2020 |
MOBL
|
Altai Capital Management, L.P.
Director |
SELL
Open market or private sale
|
Indirect | 820,183 Reduced 7.25% |
$5,765,887
$7.03 p/Share
|
Nov 09
2020 |
TCS
|
Green Equity Investors V, L.P. |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 27.54% |
$1,017,000
$10.17 p/Share
|
Nov 09
2020 |
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 14,000 Reduced 0.03% |
$3,998,120
$285.58 p/Share
|
Nov 09
2020 |
HCA
|
Jonathan B Perlin
Pres-Clinical Operations & CMO |
SELL
Open market or private sale
|
Direct | 5,531 Reduced 23.98% |
$815,048
$147.36 p/Share
|
Nov 09
2020 |
HCA
|
P. Martin Paslick
SVP and CIO |
SELL
Open market or private sale
|
Direct | 3,948 Reduced 100.0% |
$584,580
$148.07 p/Share
|
Nov 09
2020 |
HCA
|
Jane D. Englebright
SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct | 3,490 Reduced 49.86% |
$522,628
$149.75 p/Share
|
Nov 09
2020 |
SWKS
|
Robert John Terry
SVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 1,037 Reduced 8.83% |
$156,286
$150.71 p/Share
|
Nov 09
2020 |
TMX
|
Anthony Di Lucente
Former SVP & CFO |
SELL
Open market or private sale
|
Direct | 10,215 Reduced 31.49% |
$513,406
$50.26 p/Share
|
Nov 09
2020 |
MRCY
|
Mark Aslett
President and CEO |
SELL
Open market or private sale
|
Direct | 250 Reduced 0.09% |
$17,655
$70.62 p/Share
|
Nov 09
2020 |
TWNK
|
Hostess Cdm Co Invest, LLC |
SELL
Open market or private sale
|
Direct | 186,412 Reduced 100.0% |
$2,525,883
$13.55 p/Share
|
Nov 09
2020 |
PGNY
|
David J Schlanger
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 6.05% |
$1,180,000
$29.5 p/Share
|
Nov 09
2020 |
NOVA
|
Michael P Grasso
Officer |
SELL
Open market or private sale
|
Direct | 13,413 Reduced 51.06% |
$483,002
$36.01 p/Share
|
Nov 09
2020 |
LADR
|
Mark David Alexander
Director |
SELL
Open market or private sale
|
Indirect | 441 Reduced 100.0% |
$3,651
$8.28 p/Share
|
Nov 09
2020 |
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Direct | 2,508 Reduced 43.29% |
$69,246
$27.61 p/Share
|
Nov 09
2020 |
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Indirect | 2,595 Reduced 0.4% |
$71,778
$27.66 p/Share
|
Nov 09
2020 |
MGTX
|
Stuart Naylor
CHIEF DEV. OFFICER |
SELL
Open market or private sale
|
Direct | 512 Reduced 0.11% |
$7,680
$15.0 p/Share
|
Nov 09
2020 |
TCS
|
John Kristofer Galashan |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 0.19% |
$1,018,000
$10.18 p/Share
|
Nov 09
2020 |
TCS
|
Timothy John Flynn
Director |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 0.19% |
$1,018,000
$10.18 p/Share
|
Nov 09
2020 |
TCS
|
Jonathan D Sokoloff
Director |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 0.19% |
$1,018,000
$10.18 p/Share
|
Nov 09
2020 |
FREQ
|
Christopher R. Loose
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 10.03% |
$192,000
$24.0 p/Share
|
Nov 09
2020 |
EW
|
Donald E Bobo Jr
CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Indirect | 226 Reduced 35.93% |
$18,959
$83.89 p/Share
|
Nov 09
2020 |
MGNI
|
David Day
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 8.78% |
$366,900
$12.23 p/Share
|
Nov 09
2020 |
CDLX
|
John L. Klinck Jr.
Director |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 28.77% |
$600,000
$100.0 p/Share
|
Nov 09
2020 |
SPPI
|
Francois Lebel
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.61% |
$17,800
$3.56 p/Share
|
Nov 09
2020 |